Literature DB >> 222991

The composition and metabolism of high density lipoprotein subfractions.

E J Schaefer, D M Foster, L L Jenkins, F T Lindgren, M Berman, R I Levy, H B Brewer.   

Abstract

The composition and metabolism of high density lipoprotein (HDL) subfractions were investigated in seven normal individuals. Mean HDL2 (d, 1.063-1.125 g/ml) composition (by weight) was 43% protein, 28% phospholipid, 23% cholesterol, and 6% triglyceride, and mean HDL3 (d, 1.125-1.21 g/ml) composition was 58% protein, 22% phospholipid, 14% cholesterol, and 5% triglyceride. The mean apoA-I; apoA-II weight ratio was 4.75 for HDL2 and 3.65 for HDL3. HDL2 protein was proportionally slightly richer in C apolipoproteins and higher molecular weight constituents (including apoE) than HDL3. Kinetic studies utilized radiolabeled HDLA (d, 1.09-1.21 g/ml), HDL2, and HDL3 demonstrated rapid exchange of apoA-I and apoA-II radioactivity among HDL subfractions, similar fractional rates of catabolism of apoA-I and apo A-II within HDL, and similar radioactivity decay within HDL subfractions. Mean plasma residence time was 5.74 days for radiolabeled HDL2 and 5.70 days for radiolabedled HDL3. Differences in HDL protein mass among individuals were largely due to alterations in catabolism, and in general both HDL2 and HDL3 were catabolized via a plasma and a nonplasma pathway. Data from simultaneous radiolabeled very low density lipoprotein and HDL studies in 2 individuals are consistent with the concept that apoC-II and apoC-III are catabolized at a different rate than are apo A-I and apo A-II within the HDL density range.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222991     DOI: 10.1007/bf02533471

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  46 in total

Review 1.  Lipoprotein apoprotein metabolism.

Authors:  E J Schaefer; S Eisenberg; R I Levy
Journal:  J Lipid Res       Date:  1978-08       Impact factor: 5.922

2.  Lipoprotein geometry. II. Apoprotein exchange in human plasma high density lipoprotein.

Authors:  T E Grow; M Fried
Journal:  Biochem Biophys Res Commun       Date:  1977-03-07       Impact factor: 3.575

3.  Dynamic properties of human high density lipoprotein apoproteins.

Authors:  J Shepherd; J R Patsch; C J Packard; A M Gotto; O D Taunton
Journal:  J Lipid Res       Date:  1978-03       Impact factor: 5.922

4.  Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.

Authors:  E A Nikkilä; M R Taskinen; M Kekki
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

Review 5.  The plasma lipoproteins.

Authors:  J C Osborne; H B Brewer
Journal:  Adv Protein Chem       Date:  1977

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Precipitation of 125 I-labeled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins.

Authors:  J J Albers; F Aladjem
Journal:  Biochemistry       Date:  1971-08-31       Impact factor: 3.162

8.  Apoprotein composition of very low density lipoproteins of human serum.

Authors:  J P Kane; T Sata; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions.

Authors:  L B Vitello; A M Scanu
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

10.  Secretion of the arginine-rich and A-I apolipoproteins by the isolated perfused rat liver.

Authors:  T E Felker; M Fainaru; R L Hamilton; R J Havel
Journal:  J Lipid Res       Date:  1977-07       Impact factor: 5.922

View more
  7 in total

1.  Tyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular Diels-Alder cyclization.

Authors:  Roman Shchepin; Matias N Möller; Hye-young H Kim; Duane M Hatch; Silvina Bartesaghi; Balaraman Kalyanaraman; Rafael Radi; Ned A Porter
Journal:  J Am Chem Soc       Date:  2010-11-19       Impact factor: 15.419

2.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Authors:  B S Horowitz; I J Goldberg; J Merab; T M Vanni; R Ramakrishnan; H N Ginsberg
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions.

Authors:  Violeta Georgeta Trusca; Elena Valeria Fuior; Irina Cristina Florea; Dimitris Kardassis; Maya Simionescu; Anca Violeta Gafencu
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

4.  Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.

Authors:  W Sean Davidson; R A Gangani D Silva; Sandrine Chantepie; William R Lagor; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-26       Impact factor: 8.311

5.  [Disturbances of lipoprotein and fatty acid metabolism in patients with heavy injuries (author's transl)].

Authors:  G Wolfram; J Eckart; N Zöllner
Journal:  Klin Wochenschr       Date:  1980-12-15

Review 6.  Dysfunctional high-density lipoprotein.

Authors:  Hong Feng; Xiang-An Li
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

7.  Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).

Authors:  E J Schaefer; L L Kay; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.